Fundraising Fox
Safi Bio-manufactured human blood
1 known investors
Find your way into Safi Bio-manufactured human blood
Sign up to see every warm intro you have to Safi Bio-manufactured human blood
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Safi Bio-manufactured human blood team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Safi Biotherapeutics manufactures adult stem-cell derived human red blood cells (mRBCs) as a cell therapy blood transfusion product, aiming to produce them at industrial scale for civilian and military transfusion needs. Its work targets both chronic transfusion indications, such as sickle cell disease, and acute settings including hospitals and battlefields.
Investors · 1
Frequently asked questions
- What does Safi Bio-manufactured human blood do?
- Safi Biotherapeutics manufactures adult stem-cell derived human red blood cells (mRBCs) as a cell therapy blood transfusion product, aiming to produce them at industrial scale for civilian and military transfusion needs. Its work targets both chronic transfusion indications, such as sickle cell disease, and acute settings including hospitals and battlefields.
- Who are Safi Bio-manufactured human blood's investors?
- Safi Bio-manufactured human blood's investors include J2 Ventures.